Acarix
0.31 SEK
-0.95 %
Less than 1K followers
ACARIX
First North Stockholm
Medical Equipment & Services
Health Care
Overview
Financials & Estimates
Ownership
Investor consensus
-0.95 %
+11.55 %
-4.85 %
+31.93 %
+25.10 %
+14.18 %
+9.08 %
-70.03 %
-95.75 %
Acarix is a diagnostics company. The company has developed a technology that enables the identification of coronary artery disease. The company's product is a non-invasive test that is applied with a patch to the patient to analyze sounds from the heart. The business is conducted primarily within the Nordic market. The company was founded in 2009 as a spin-off from Coloplast. The headquarters are located in Malmö.
Read moreMarket cap
389.53M SEK
Turnover
690.51K SEK
Revenue
6.2M
EBIT %
-1,070.48 %
P/E
-
Dividend yield-%
-
Revenue and EBIT-%
Revenue M
EBIT-% (adj.)
EPS and dividend
EPS (adj.)
Dividend %
Financial calendar
12.2
2026
Annual report '25
All
Press releases
ShowingAll content types
Invitation to presentation of Acarix´s third quarter 2025 report
Acarix Publishes Interim Report, Third quarter 2025
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools